GUARDANT360 RESPONSE Trademark

Trademark Overview


On Monday, June 21, 2021, a trademark application was filed for GUARDANT360 RESPONSE with the United States Patent and Trademark Office. The USPTO has given the GUARDANT360 RESPONSE trademark a serial number of 90786327. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Monday, July 21, 2025. This trademark is owned by Guardant Health, Inc.. The GUARDANT360 RESPONSE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Healthcare services, namely, providing a database in the field of cancer related information and featuring inputting and collection of data and information for treatment and diagnostic purposes; medical testing for diagnostic or treatment purposes; providing cancer detection and monitoring services in the nature of providing medical diagnostic testing services consisting primarily of chemical analysis, genomic and molecular analysis, and use of bioinformatics tools for cancer detection; providing a website featuring information in the field of cancerous diseases for diagnostic and treatment purposes; providing medical information to healthcare professionals; providing a website featuring information in the field of cancerous diseases for medical purposes
guardant360 response

General Information


Serial Number90786327
Word MarkGUARDANT360 RESPONSE
Filing DateMonday, June 21, 2021
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateMonday, July 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 25, 2022

Trademark Statements


Pseudo MarkGUARDANT THREE HUNDRED SIXTY RESPONSE GUARDANT THIRTY SIX ZERO RESPONSE GUARDANT THREE SIX ZERO RESPONSE
Goods and ServicesHealthcare services, namely, providing a database in the field of cancer related information and featuring inputting and collection of data and information for treatment and diagnostic purposes; medical testing for diagnostic or treatment purposes; providing cancer detection and monitoring services in the nature of providing medical diagnostic testing services consisting primarily of chemical analysis, genomic and molecular analysis, and use of bioinformatics tools for cancer detection; providing a website featuring information in the field of cancerous diseases for diagnostic and treatment purposes; providing medical information to healthcare professionals; providing a website featuring information in the field of cancerous diseases for medical purposes
NOT AVAILABLE"RESPONSE"

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 7, 2021
Primary Code044
First Use Anywhere DateTuesday, June 22, 2021
First Use In Commerce DateTuesday, June 22, 2021

Trademark Owner History


Party NameGuardant Health, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Party NameGuardant Health, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Trademark Events


Event DateEvent Description
Thursday, June 24, 2021NEW APPLICATION ENTERED
Tuesday, September 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 13, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, December 2, 2021ASSIGNED TO EXAMINER
Monday, December 13, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, December 13, 2021EXAMINERS AMENDMENT E-MAILED
Monday, December 13, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, December 17, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 25, 2022PUBLISHED FOR OPPOSITION
Wednesday, January 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 20, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, March 21, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, September 20, 2022SOU EXTENSION 1 FILED
Tuesday, September 20, 2022SOU EXTENSION 1 GRANTED
Thursday, September 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 21, 2023SOU EXTENSION 2 FILED
Tuesday, March 21, 2023SOU EXTENSION 2 GRANTED
Tuesday, June 6, 2023ASSIGNED TO EXAMINER
Friday, September 22, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 22, 2023SOU EXTENSION 3 FILED
Friday, September 22, 2023SOU EXTENSION 3 GRANTED
Tuesday, March 19, 2024SOU EXTENSION 4 FILED
Tuesday, March 19, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 19, 2024SOU EXTENSION 4 GRANTED
Thursday, September 19, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, March 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 19, 2024USE AMENDMENT FILED
Sunday, November 24, 2024STATEMENT OF USE PROCESSING COMPLETE
Sunday, November 24, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 26, 2024NON-FINAL ACTION E-MAILED
Tuesday, November 26, 2024SU - NON-FINAL ACTION - WRITTEN
Tuesday, November 26, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 25, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, February 25, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, May 28, 2025TEAS PETITION TO REVIVE RECEIVED
Wednesday, July 9, 2025ASSIGNED TO PETITION STAFF
Tuesday, July 15, 2025NOTICE OF REVIVAL - E-MAILED
Thursday, July 17, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 17, 2025ASSIGNED TO LIE
Monday, July 21, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 21, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, July 17, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 15, 2025PETITION GRANTED - RESPONSE RECEIVED